![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results
31 juil. 2014 16h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review
01 mai 2014 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
30 avr. 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will host a fireside chat at the Deutsche Bank Securities 39th...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
07 avr. 2014 07h00 HE
|
Idenix Pharmaceuticals
Idenix Reports Positive Proof-of-Concept Data for Lead Nucleotide Prodrug, IDX21437
Idenix on Track to Initiate All-Oral Pan-Genotypic Phase II Combination Clinical Study of IDX21437 and...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of the European Association for the Study of the Liver
24 mars 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case
24 mars 2014 07h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
14 mars 2014 07h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., March 14, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2013 Financial Results
27 févr. 2014 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
26 févr. 2014 08h00 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present at the Cowen & Company 34th Annual Health Care...
![Idenix Pharmaceuticals logo](/news-release/logo/292339/0/292339.jpg?lastModified=12%2F10%2F2016%2003%3A15%3A26&size=2)
Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference
07 févr. 2014 08h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat discussion at the 2014 Leerink...